Amedisys Inc (STU:ADY)
€ 87 0 (0%) Market Cap: 2.90 Bil Enterprise Value: 3.24 Bil PE Ratio: 0 PB Ratio: 2.87 GF Score: 85/100

Amedisys Inc at Stephens NASH Investment Conference (Virtual) Transcript

Nov 19, 2020 / 08:00PM GMT
Release Date Price: €200 (-0.99%)
Scott J. Fidel
Stephens Inc., Research Division - MD & Analyst

Okay. Great. I think we're ready to get started with our next fireside chat. I'm Scott Fidel, I'm the health care services analyst with Stephens. We're delighted to have the team from Amedisys with us for a discussion.

Here from the company today, we have Paul Kusserow, the Chief Executive Officer; Chris Gerard, who is Chief Operating Officer; Scott Ginn, who is the Chief Financial Officer; and Nick Muscato, who's in Finance and Investor Relations.

So first of all, thanks to all of you for joining us today. We really appreciate you being at the Stephens conference once again. So it's great to have you.

And Paul, I thought maybe just to get started, always interested in your sort of latest and greatest on sort of how you're thinking about the world right now and some thoughts on what you'd advise we should all be thinking about. And then we'll dig into some Q&A.

Paul Berthold Kusserow
Amedisys, Inc. - Chairman, President & CEO

Sure. Great. Thanks, Scott.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot